The validity of self-reported antiretroviral use in persons living with HIV: a population-based study. (28th January 2018)
- Record Type:
- Journal Article
- Title:
- The validity of self-reported antiretroviral use in persons living with HIV: a population-based study. (28th January 2018)
- Main Title:
- The validity of self-reported antiretroviral use in persons living with HIV
- Authors:
- Grabowski, Mary K.
Reynolds, Steven J.
Kagaayi, Joseph
Gray, Ronald H.
Clarke, William
Chang, Larry W.
Nakigozi, Gertrude
Laeyendecker, Oliver
Redd, Andrew D.
Billioux, Veena
Ssekubugu, Robert
Nalugoda, Fred
Wawer, Maria J.
Serwadda, David
Quinn, Thomas C.
Tobian, Aaron A.R. - Abstract:
- Abstract : Objective: To assess the validity of self-reported antiretroviral therapy use (ART) using population-based cohort data. Methods: Self-reported ART use and nonuse was compared with a validated laboratory assay in 557 HIV-positive participants in the Rakai Community Cohort Study surveyed between September and December 2011 in Rakai, Uganda. The study population included participants from seven communities, including one fishing community with high HIV prevalence (∼41%). ART use was assayed using liquid chromatography–tandem mass spectrometry, which detects 20 antiretroviral drugs. HIV viral load measurements were also obtained. Individuals with at least two antiretroviral drugs detected were considered to be using ART. Results: One hundred and fifty-three (27%) participants self-reported ART use of whom 148 (97%) had at least two antiretroviral drugs detected. There were at least two antiretroviral drugs detected in 11% ( n = 44/404) of individuals with no self-reported ART use. Overall, the specificity of self-reported ART use was 99% (95% CI 97–100%) and the sensitivity was 77% (70–83%). Positive and negative predictive values were 97% (95% CI 93–99%) and 89% (95% CI 86–92%), respectively. Nondisclosure of ART use was significantly more common in younger persons (<30 years) and among those in trading occupations. Conclusion: Self-reported ART use has high specificity and moderate sensitivity providing reasonable, but conservative estimates of population-based ARTAbstract : Objective: To assess the validity of self-reported antiretroviral therapy use (ART) using population-based cohort data. Methods: Self-reported ART use and nonuse was compared with a validated laboratory assay in 557 HIV-positive participants in the Rakai Community Cohort Study surveyed between September and December 2011 in Rakai, Uganda. The study population included participants from seven communities, including one fishing community with high HIV prevalence (∼41%). ART use was assayed using liquid chromatography–tandem mass spectrometry, which detects 20 antiretroviral drugs. HIV viral load measurements were also obtained. Individuals with at least two antiretroviral drugs detected were considered to be using ART. Results: One hundred and fifty-three (27%) participants self-reported ART use of whom 148 (97%) had at least two antiretroviral drugs detected. There were at least two antiretroviral drugs detected in 11% ( n = 44/404) of individuals with no self-reported ART use. Overall, the specificity of self-reported ART use was 99% (95% CI 97–100%) and the sensitivity was 77% (70–83%). Positive and negative predictive values were 97% (95% CI 93–99%) and 89% (95% CI 86–92%), respectively. Nondisclosure of ART use was significantly more common in younger persons (<30 years) and among those in trading occupations. Conclusion: Self-reported ART use has high specificity and moderate sensitivity providing reasonable, but conservative estimates of population-based ART use. There is more under-reporting of ART use among younger persons and traders suggesting a need for more research on barriers to self-reporting of ART use in these sub-groups. Abstract : Supplemental Digital Content is available in the text … (more)
- Is Part Of:
- AIDS. Volume 32:Number 3(2018)
- Journal:
- AIDS
- Issue:
- Volume 32:Number 3(2018)
- Issue Display:
- Volume 32, Issue 3 (2018)
- Year:
- 2018
- Volume:
- 32
- Issue:
- 3
- Issue Sort Value:
- 2018-0032-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-01-28
- Subjects:
- AIDS -- antiretroviral therapy -- combination HIV prevention -- HIV -- self-report -- Sub-Saharan Africa -- Uganda -- validity
AIDS (Disease) -- Periodicals
Acquired Immunodeficiency Syndrome
AIDS (Disease)
Periodicals
Periodicals
616.9792005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00002030-000000000-00000 ↗
http://journals.lww.com/aidsonline/pages/default.aspx?desktopMode=true ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/QAD.0000000000001706 ↗
- Languages:
- English
- ISSNs:
- 0269-9370
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0773.083000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8734.xml